- Home
- SKX vs SNN Comparison
SKX vs SNN Comparison
Compare SKX & SNN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- SKX
- SNN
- Stock Information
- Founded
- SKX 1992
- SNN 1856
- Country
- SKX United States
- SNN United Kingdom
- Employees
- SKX N/A
- SNN N/A
- Industry
- SKX Shoe Manufacturing
- SNN Industrial Specialties
- Sector
- SKX Consumer Discretionary
- SNN Health Care
- Exchange
- SKX Nasdaq
- SNN Nasdaq
- Market Cap
- SKX 9.3B
- SNN 12.6B
- IPO Year
- SKX 1999
- SNN 1999
- Fundamental
- Price
- SKX $63.11
- SNN $30.51
- Analyst Decision
- SKX Buy
- SNN Hold
- Analyst Count
- SKX 12
- SNN 3
- Target Price
- SKX $69.18
- SNN $27.50
- AVG Volume (30 Days)
- SKX 5.2M
- SNN 913.5K
- Earning Date
- SKX 07-24-2025
- SNN 07-31-2025
- Dividend Yield
- SKX N/A
- SNN 2.35%
- EPS Growth
- SKX 9.64
- SNN 56.15
- EPS
- SKX 4.16
- SNN 0.47
- Revenue
- SKX $9,129,335,000.00
- SNN $5,810,000,000.00
- Revenue This Year
- SKX $7.83
- SNN $6.87
- Revenue Next Year
- SKX $6.94
- SNN $5.19
- P/E Ratio
- SKX $15.16
- SNN $32.39
- Revenue Growth
- SKX 10.66
- SNN 4.70
- 52 Week Low
- SKX $44.50
- SNN $23.69
- 52 Week High
- SKX $78.85
- SNN $31.72
- Technical
- Relative Strength Index (RSI)
- SKX 72.40
- SNN 59.77
- Support Level
- SKX $62.41
- SNN $28.40
- Resistance Level
- SKX $62.88
- SNN $29.27
- Average True Range (ATR)
- SKX 0.20
- SNN 0.41
- MACD
- SKX -0.17
- SNN -0.05
- Stochastic Oscillator
- SKX 88.48
- SNN 75.25
About SKX Skechers U.S.A. Inc.
Skechers USA Inc is a lifestyle footwear company under the Skechers GO brand name. Products offered include various styles of women's shoes, men's shoes, girl's shoes, boy's shoes, performance shoes, and work shoes. Allied products offered are apparel, bags, eyewear, toys, and more. Its products are available for sale at department and specialty stores, athletic and independent retailers, boutiques, and internet retailers. The company's operating segments includes Wholesale and Direct-to-Consumer. It generates maximum revenue from the Wholesale segment.
About SNN Smith & Nephew SNATS Inc.
Smith & Nephew designs, manufactures, and markets orthopedic devices, sports medicine and arthroscopic technologies, and wound care solutions. Roughly 41% of the UK-based firm's revenue comes from orthopedic products, and another 30% is sports medicine and ENT. The remaining 29% of revenue is from the advanced wound therapy segment. Over half of Smith & Nephew's total revenue comes from the United States, just over 30% is from other developed markets, and emerging markets account for the remainder.